AUS
NZ
UK
CA
USA
IND
Citigroup Global Markets Australia Pty Limited, along with its associated Citigroup group entities, has officially declared becoming a substantial shareholder in Healius Limited (ASX:HLS) as of 30 June 2026. The group holds a combined relevant interest of 38,026,069 fully paid ordinary shares, equating to 5.2366% of the company's voting power. This disclosure, submitted on 3 July 2026 through a Form 603 Notice of Initial Substantial Holder in compliance with Section 671B of the Corporations Act, indicates that the majority of this interest arises from securities lending arrangements involving multiple Citigroup entities across Australia, the United States, and the United Kingdom. For Healius investors, the crossing of the 5% substantial shareholder threshold by a major global financial institution marks a significant event, though the predominance of securities lending in this holding calls for careful analysis.
Key Points
- Company: Healius Limited (ASX:HLS)
- Citigroup Global Markets Australia Pty Limited and related entities became substantial shareholders on 30 June 2026
- Total relevant interest: 38,026,069 ordinary fully paid shares, representing 5.2366% voting power
- Shares held across four Citigroup entities: Citibank N.A. Sydney Branch (24,101,707 shares), Citigroup Global Markets Australia Pty Limited (1,116,245 shares), Citigroup Global Markets Inc (1,970,051 shares), and Citigroup Global Markets Limited (10,838,066 shares)
- Relevant interests primarily arise from securities lending agreements (AMSLA, GMSLA, MSLA) and standard market contracts
- Investors should monitor potential changes in Citigroup's relevant interest due to securities lending operations
Aggregation of Citigroup’s Holdings Across Four Entities Leads to 5.2366% Voting Stake in Healius
The 5.2366% relevant interest held by Citigroup in Healius is the combined result of holdings across four separate entities rather than a single direct market acquisition. Citibank N.A. Sydney Branch holds the largest portion with 24,101,707 shares, acting as Agent Lender and as holder of securities subject to return obligations under securities lending agreements.
The other three entities—Citigroup Global Markets Australia Pty Limited (1,116,245 shares), Citigroup Global Markets Inc (1,970,051 shares), and Citigroup Global Markets Limited (10,838,066 shares)—hold their interests through contracts involving securities lending agreements and, in some cases, ordinary course market transactions. Together, these holdings total 38,026,069 shares, surpassing the 5% substantial shareholder disclosure threshold mandated by the Corporations Act.
Implications of Securities Lending Agreements for Understanding Citigroup’s Stake
The nature of Citigroup's substantial shareholder position is crucial for Healius investors to interpret. The holdings arise via Australian Master Securities Lending Agreements (AMSLA), Global Master Securities Lending Agreements (GMSLA), and Master Securities Lending Agreements (MSLA). These agreements involve transferring securities between lenders and borrowers with an obligation to return, meaning economic ownership and legal registration may differ from the entity disclosing the relevant interest.
Securities lending is common in institutional finance, facilitating activities such as short selling and hedging. The company update clarifies that voting rights for loaned securities rest with the borrowers, not Citigroup, and that there are no restrictions on these voting rights. The return date for the loans is unspecified, with both parties retaining rights for early recall or return.
Citibank N.A. Sydney Branch’s Role as Agent Lender in Managing 24.1 Million Shares
The largest portion of Citigroup’s relevant interest is held by Citibank N.A. Sydney Branch, which manages 24,101,707 shares. It holds this interest both as Agent Lender under a Securities Lending Agency Agreement (SLAA) and as holder of securities subject to return obligations under securities lending agreements.
As Agent Lender, Citibank N.A. Sydney Branch administers securities on behalf of underlying lenders, managing lending parameters such as designated accounts, lendable limits, collateral requirements, and cash reinvestment, as detailed in Annexure A of the company update. Although the agent lender can recall securities upon lender instruction, termed loans typically do not permit early return, reflecting mutual agreement between lender and borrower. The registered holder for these shares is listed as "Various," representing the diverse group of lenders involved.
Citicorp Nominees Pty Limited Acts as Registered Holder for Three Citigroup Entities
While four Citigroup entities hold relevant interests, three of them—Citigroup Global Markets Australia Pty Limited, Citigroup Global Markets Inc, and Citigroup Global Markets Limited—have their shares registered under Citicorp Nominees Pty Limited. This nominee structure is standard in institutional investing, allowing a custodian to hold securities on behalf of multiple beneficial owners or related entities under one registration.
For Healius shareholders reviewing the register, the Citigroup group’s 38,026,069 shares may appear under Citicorp Nominees Pty Limited and "Various," potentially obscuring the aggregate position without consulting the substantial shareholder notice.
Healius’s Role in the Australian Healthcare Sector Contextualizes the Shareholding Disclosure
Healius Limited is among Australia's largest publicly listed healthcare companies, focusing on pathology and diagnostic imaging. The company has undergone strategic reviews and portfolio restructuring in recent years, attracting significant interest from institutional and retail investors. Citigroup’s crossing of the 5% substantial shareholder threshold occurs amid this heightened market attention.
The company update contains no information on Citigroup’s intentions regarding the Healius shares, nor any statements from Healius management. This disclosure fulfills a legal requirement upon crossing the 5% threshold and does not indicate strategic accumulation, takeover interest, or other corporate actions. Investors should distinguish between regulatory disclosure obligations and signals of investment intent.
Global Distribution of Citigroup Entities Highlights the International Securities Lending Network
The four Citigroup entities involved are headquartered across three continents, underscoring the global nature of institutional securities lending. Citibank N.A. Sydney Branch and Citigroup Global Markets Australia Pty Limited are based in Sydney, Australia; Citigroup Global Markets Inc operates from New York, USA; and Citigroup Global Markets Limited is located in London, UK.
All entities are related bodies corporate within the Citigroup group, and their combined relevant interests are aggregated for substantial shareholder disclosure. The international lending network allows shares to be lent and returned across jurisdictions as part of routine operations, with the composition of the aggregate position potentially changing over time without immediate disclosure unless thresholds are crossed.
Standard Securities Lending Agreements Govern the Return Obligations
The relevant interests held by Citigroup Global Markets Australia Pty Limited, Citigroup Global Markets Inc, and Citigroup Global Markets Limited are governed by industry-standard agreements: the AMSLA, GMSLA, and MSLA. These documents regulate lending terms, including margin, collateral, default events, and party rights.
The company update states that Citigroup will provide copies of the relevant agreements to Healius or ASIC upon request. Similarly, the Securities Lending Agency Agreement for Citibank N.A. Sydney Branch’s position is available to the company or ASIC if requested. These provisions ensure regulatory transparency, and the use of standard agreements means the terms across the 38,026,069 share position align with market norms, despite varied parties and transfer dates.
Regulatory Significance of the 5% Threshold Under Section 671B of the Corporations Act
The Form 603 Notice filed by Citigroup is a mandatory disclosure triggered by Section 671B of the Corporations Act 2001 (Cth). Australian law requires any person or group of associated entities acquiring a relevant interest of 5% or more in a listed company’s voting shares to notify the company and ASX within two business days of awareness. Citigroup became a substantial holder on 30 June 2026, with the notice dated 3 July 2026, complying with this timeframe.
Following this, Citigroup must lodge Form 604 Change of Substantial Holder Notices for any 1% or greater changes in relevant interest and a Form 605 Ceasing to be a Substantial Holder Notice if holdings fall below 5%. This ongoing disclosure ensures market transparency regarding Citigroup’s position in Healius. The filing was signed by Anja Frederikson of Citigroup Global Markets Australia Pty Limited.
Key Considerations for Healius Investors After Citigroup’s Disclosure
Investors should closely monitor whether Citigroup’s relevant interest in Healius increases, remains stable, or is unwound as securities lending agreements mature or are recalled. Given that securities lending underpins much of the position, holdings may fluctuate rapidly. Any change of 1% or more will trigger further regulatory disclosures, providing ongoing market insight.
Additionally, large securities lending positions can correlate with elevated short interest, as borrowers often include hedge funds or other market participants who on-lend shares. However, the company update does not reveal borrower identities, borrowing purposes, or current short interest levels in Healius. The immediate impact on Healius’s share price from this disclosure was not evident from public information. Investors are advised to consider the full investment context and consult licensed financial advisers before acting on changes to the substantial shareholder register.
